Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF)

Journal of Cystic Fibrosis

Volumn 10, Issue 2, 2011, Pages 133-139

  Maeda, Yasunori ^a,b   Elborn, J Stuart ^a,c   Parkins, Michael D ^a,d   Reihill, James ^c   Goldsmith, Colin E ^a   Coulter, Wilson A ^e   Mason, Charlene ^a   Millar, B Cherie ^b   Dooley, James S G ^b   Lowery, Colm J ^c   Ennis, Madeleine ^c   Rendall, Jacqueline C ^a   Moore, John E ^a,b  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF CALGARY   (Canada)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; PENICILLIN G;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CYSTIC FIBROSIS; CYTOTOXICITY; GENE SEQUENCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION STRUCTURE; SEQUENCE ANALYSIS; SPECIES DISTRIBUTION; SPECIES IDENTIFICATION; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS AUSTRALIS; STREPTOCOCCUS CRISTATUS; STREPTOCOCCUS INFANTIS; STREPTOCOCCUS MITIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SPUTUM; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; VIRIDANS STREPTOCOCCI; VIRULENCE;

EID: 79952448896     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.11.003     Document Type: Article

References (21)

1. Hardie J.M., Whiley R.A. Classification and overview of the genera Streptococcus and Enterococcus. J Appl Microbiol 1997, 83:S1-S11.
2. Tunney M.M., Field T.R., Moriarty T.F., Patrick S., Doering G., Muhlebach M.S., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008, 177:995-1001.
3. Parkins M.D., Sibley C.D., Surette M.G., Rabin H.R. The Streptococcus milleri group-an unrecognized cause of disease in cystic fibrosis: a case series and literature review. Pediatr Pulmonol 2008, 43:490-497.
4. Millar B.C., Xu J., Moore J.E. Risk assessment models and contamination management: implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology. J Clin Microbiol 2002, 40:1575-1580.
5. Maeda Y, Goldsmith CE, Coulter WA, Mason C, Dooley JSD, Lowery CJ, Millar BC, Moore JE. Comparasion of five gene loci (rnpB, 16S rRNA, 16S-23S rRNA, sodA & dnaJ) to aid in the molecular identification of viridans group streptococci (VGS) and pneumococci. Brit J Biomed Sci (submitted for publication).
6. Chen C.C., Teng L.J., Chang T.C. Identification of clinically relevant viridans group streptococci by sequence analysis of the 16S-23S ribosomal DNA spacer region. J Clin Microbiol 2004, 42:2651-2657.
7. CLSI. Clinical and Laboratory Standards Institute (CLSI): Performance standards for antimicrobial susceptibility testing. Document M100-S15. Wayne, Pennsylvania, USA 2005.
8. Versalovic J., Koeuth T., Lupski J.R. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res 1991, 19:6823-6831.
9. Rogers G.B., Carroll M.P., Serisier D.J., Hockey P.M., Jones G., Bruce K.D. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling. J Clin Microbiol 2004, 42:5176-5183.
10. Klepac-Ceraj V., Lemon K.P., Martin T.R., Allgaier M., Kembel S.W., Knapp A.A., et al. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ Microbiol 2010, 12:1293-1303.
11. Sibley C.D., Parkins M.D., Rabin H.R., Duan K., Norgaard J.C., Surette M.G. A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients. Proc Natl Acad Sci USA 2008, 105:15070-15075.
12. Tazumi A., Maeda Y., Goldsmith C.E., Coulter W.A., Mason C., Millar B.C., et al. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF). J Antimicrob Chemother 2009, 64:501-506.
13. Rickard A.H., Gilbert P., High N.J., Kolenbrander P.E., Handley P.S. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 2003, 11:94-100.
14. Chalmers N.I., Palmer R.J., Cisar J.O., Kolenbrander P.E. Characterization of a Streptococcus sp.-Veillonella sp. community micromanipulated from dental plaque. J Bacteriol 2008, 190:8145-8154.
15. Hsu S.D., Cisar J.O., Sandberg A.L., Kilian M. Adhesive properties of viridans streptococcal species. Microbiol Ecol Health Dis 1994, 7:125-137.
16. Cisar J.O., Sandberg A.L., Reddy G.P., Abeygunawardana C., Bush C.A. Structural and antigenic types of cell wall polysaccharides from viridans group streptococci with receptors for oral actinomyces and streptococcal lectins. Infect Immun 1997, 65:5035-5041.
17. Cisar J.O., Sandberg A.L., Abeygunawardana C., Reddy G.P., Bush C.A. Lectin recognition of host-like saccharide motifs in streptococcal cell wall polysaccharides. Glycobiology 1995, 5:655-662.
18. Hughes C.V., Kolenbrander P.E., Andersen R.N., Moore L.V. Coaggregation properties of human oral Veillonella spp.: relationship to colonization site and oral ecology. Appl Environ Microbiol 1998, 54:1957-1963.
19. Palmer R.J., Diaz P.I., Kolenbrander P.E. Rapid succession within the Veillonella population of a developing human oral biofilm in situ. J Bacteriol 2006, 188:4117-4124.
20. Palmer R.J., Gordon S.M., Cisar J.O., Kolenbrander P.E. Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque. J Bacteriol 2003, 185:3400-3409.
21. Lerrer B., Zinger-Yosovich K.D., Avrahami B., Gilboa-Garber N. Honey and royal jelly, like human milk, abrogate lectin-dependent infection-preceding Pseudomonas aeruginosa adhesion. ISME J 2007, 1:149-155.